Yahoo News: Volunteers needed for COVID-19 vaccine trial at UC
UC researchers join nationwide trial of Moderna vaccine
Yahoo News posted a story originated by WCPO-TV, Channel 9 on UC and UC Health joining a nationwide trial of the Moderna vaccine for COVID-19. Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases is the medical director of the trial at UC.
UC is one of 89 sites across the country taking part in the trial which is looking for a wide range of participants from the age of 18 and up, but researchers are trying to ensure that they have a diverse and representative study group here locally.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases/Photo/Joe Fuqua III/UC Creative + Brand
"We've been reaching out to community leaders in both the Latino and Hispanic communities," Fichtenbaum said. "We've also been reaching out to the African-American/Black community for the kinds of targets we're interested in, which is having about at least 30% of our study be from underrepresented populations so they have a chance to participate."
The first dose in the local study was administed at the UC College of Medicine on August 25, 2020.
Watch the full report here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.